drugset / Trial / NCT02702323
Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study
Phase 2/3
Unknown
40 enrolled
Zhejiang Cancer Hospital
First Affiliated Hospital of Wenzhou Medical University · collabFirst Affiliated Hospital of Zhejiang University · collabNingbo No.2 Hospital · collabSecond Affiliated Hospital, School of Medicine, Zhejiang University · collabThe Central Hospital of Lishui City · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This study mainly evaluate the clinical effect of Apatinib in the treatment of patients with pulmonary metastasis of hepatocellular carcinoma.Half of participants will receive Apatinib and transcatheter arterial chemoembolization (TACE) therapy in combination,while the other half will receive TACE therapy alone.
Timeline
- Start
- 2016-03
- Primary completion
- 2018-03
- Completion
- 2019-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivoceranib | Small molecule | 500 mg | Oral |